Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial REPLY

被引：0
|
作者：
Decroos, Francis Char
Reed, David
Adam, Murtaza K.
Salz, David
Gupta, Omesh P.
Ho, Allen C.
Regillo, Carl D.
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [1] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 182 : 204 - 205
  • [2] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial
    Decroos, Francis Char
    Reed, David
    Adam, Murtaza K.
    Salz, David
    Gupta, Omesh P.
    Ho, Allen C.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 180 : 142 - 150
  • [3] Four-year results of a Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration
    Yoshida, Shigeo
    Umeno, Yumi
    Noda, Rie
    Ishibashi, Kouki
    Dake, Shoutarou
    Haruta, Masatoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [4] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [5] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
  • [6] Clinical outcome using a modified treat-and-extend protocol for neovascular age-related macular degeneration
    Vofo, Brice Nguedia
    Cnaany, Yaacov
    Chowers, I
    BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [7] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The ARIES Study: A Randomized Clinical Trial
    Mitchell, Paul
    Holz, Frank G.
    Hykin, Philip
    Midena, Edoardo
    Souied, Eric
    Allmeier, Helmut
    Lambrou, George
    Schmelter, Thomas
    Wolf, Sebastian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (09): : 1911 - 1920
  • [8] Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact
    Shienbaum, Gary
    Gupta, Omesh P.
    Fecarotta, Christopher
    Patel, Avni H.
    Kaiser, Richard S.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (03) : 468 - 473
  • [9] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Mohamed Kamel Soliman
    Nicolas Tuli
    Thomas K. Lee
    William A. Britton
    Raman Tuli
    International Journal of Retina and Vitreous, 7
  • [10] Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration
    Hidetaka Matsumoto
    Takashi Hiroe
    Masahiro Morimoto
    Kensuke Mimura
    Arisa Ito
    Hideo Akiyama
    Japanese Journal of Ophthalmology, 2018, 62 : 144 - 150
12345